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Abstract: Angiosarcomas are malignant vascular neoplasms that usually occur in deep soft tissue. Patients di-
agnosed with angiosarcoma are usually elderly and are given poor prognoses. Pediatric splenic angiosarcoma is 
extremely rare, and its pathogenesis is not as well understood as that of older patients. We describe a case of 
4-year-old male who had undergone splenectomy for splenic mass. Histopathological examination revealed primary 
splenic angiosarcoma. We then reviewed published literatures to characterize its clinical characteristics.
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Introduction
Angiosarcomas are malignant tumors of the 
inner lining of blood vessels that recapitulate 
the histological features of normal vasculature 
and endothelium. Most tumors are in the deep 
muscles of the lower extremities or the abdomi-
nal cavity. Patients with angiosarcoma are usu-
ally in their 60 s. The prognosis for this cancer 
is poor. 
Primary splenic angiosarcoma arises from the 
vascular endothelium of the spleen. The mean 
age at presentation is between 50 and 60 
years of age [1, 2]. This malignancy is extremely 
rare, and pediatric primary splenic angiosarco-
ma is rarer still: Only approximately 200 cases 
of primary splenic angiosarcoma have been 
reported worldwide, and a very small portion of 
these were in patients aged 18 years or 
younger.
In this study, we present a case of primary 
splenic angiosarcoma of a 4-year-old male who 
had undergone a total splenectomy. We then 
summarize the information on pediatric splenic 
angiosarcoma that is available in the literature 
in the English language to date, and place the 
new information gained from this case in the 
context of what is known.
Materials and methods
Case
Pediatric splenic angiosarcoma was diagno- 
sed at Severance Hospital, Yonsei University 
College of Medicine, Seoul, Republic of Korea. 
Representative sections were excised, stained 
with hematoxylin and eosin (H&E), and reviewed 
by three pathologists (S. K. Kim, T. Chung, and 
C. K. Park).
Immunohistochemistry
Tumors were fixed in formalin and embedded in 
paraffin. Briefly, 5-μm thick sections were cut 
using a microtome, transferred onto adhesive 
slides, and dried at 62°C for 30 min. Immuno- 
histochemistry with antibodies against CD31, 
CD34, Ki67 (Catalog#s M0823, M7165, and 
M7240, respectively; DAKO, Glostrup, Denma- 
rk), Fli-1 (Catalog# 254M-15, Cell Marque, 
Rocklin, CA, USA) was performed with an auto-
mated immunohistochemical staining instru-
ment (Ventana Discovery® XT, Ventana Medical 
System, Inc., Oro Valley, AZ, USA).
Results
Case
A 4-year-old male patient was referred to our 
hospital after an incidental detection of a splen-
ic mass. His medical history was unremarkable, 
except that he had been born during the 35th 
week of gestation with a birth weight of 1.9 kg. 
On radiological examination, abdominal com-
puted tomography revealed splenomegaly with 
heterogeneity of the splenic parenchyma, with 
hypervascularity and necrosis (Figure 1A). 
Multiple enhancing lesions were noted in the 
liver (Figure 1B). There was no specific atypical 
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finding in laboratory tests, although the 
patient’s hemoglobin level was 9.1 g dL-1 on 
admission, which was slightly low. 
The patient underwent a total splenectomy and 
a wedge-resection of one of the hepatic nod-
ules. The spleen measured 16 cm along the 
Figure 1. Results from radiological and gross examination. A and B. Computed tomography of abdomen. Note sple-
nomegaly with heterogeneous hypervascular and necrotic portions within the spleen and the multiple enhancing 
lesions within the liver, indicated by the arrow. C. Gross image of the specimen. Note heterogeneous cut surface with 
multiple ill-defined grayish soft solid areas, dark red hemorrhagic or sponge-like areas, and yellowish necrotic areas.
Figure 2. Images from histological examination after H&E staining of specimens of the spleen at different mag-
nification. A. 40× magnification; note hypercellular area with slit-like spaces, necrosis, and hemorrhage. B. 100× 
magnification; note that the slit-like spaces containing red blood cells anastomose with each other. C. Magnifica-
tion 200×; note that the lining cells are highly pleomorphic with prominent nucleoli. D. Magnification 400×; note 
frequent mitoses.
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long axis and weighed 466 g. Bisection revealed 
that the cut surface was variegated, with con-
gestions, hemorrhages, multifocal necrosis, 
and ill-defined solid lesions (Figure 1C). Tissue 
sections were collected from various parts of 
the spleen and stained with H&E for histologi-
cal examination under a light microscope.
Microscopic examination revealed hypercellu-
lar lesions with slit-like spaces, and confirmed 
the presence of necrosis and hemorrhage 
(Figure 2A). Under high magnification (Figure 
2B), it was apparent that the slit-like spaces 
were irregularly anastomosed with one another 
and filled with red blood cells. These complex 
anastomosing channels were lined with atypi-
cal cells with short-spindle or epithelioid cyto-
logical features, eosinophilic cytoplasm, irregu-
lar nuclear shapes, and prominent nucleoli 
(Figure 2C, 2D). Mitotic cells were common: 
there was an average of approximately 50 
mitotic cells in 10 high-power fields.
Immunohistochemical staining revealed that 
vascular markers CD31, CD34, and Fli-1 had a 
strong positive signal in the tumor cells (Figure 
3A-C). Staining for Ki-67 was positive in approx-
imately 30% of tumor cells, revealing increased 
proliferative activity of tumor cells (Figure 3D). 
The wedge-shaped resected hepatic lesion had 
similar histological findings and immunohisto-
chemical profiles as did the tumor cells.
These results allowed us to make a diagnosis 
of primary splenic angiosarcoma with multiple 
hepatic metastases. The patient was under-
went a paclitaxel-based chemotherapy, and 
was scheduled for a 2-month follow-up radio-
logical examination. This exam revealed that 
the disease status was stable. The patient died 
12 months after the surgery.
Clinical features of pediatric splenic angiosar-
coma
The cases of pediatric splenic angiosarcoma 
that we collected from a literature search are 
presented in Table 1. If the single case dis-
cussed here is included, there have been 11 
reported cases of this condition. Patients 
Figure 3. Results from immunohistochemical staining of specimens for the proteins: A. CD31; B. CD34; C. Fli-1; D. 
Ki-67.
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ranged from 1 to 17 years old, with a mean age 
of 9.27 years. Pediatric splenic angiosarcoma 
affected males and females equally. The 
lesions ranged from 5 to 19 cm in diameter, 
with a mean of 13.14 cm. Most tumors metas-
tasized to the liver and then to bone. The over-
all survival rate was 40% (4 out of 10 patients 
survived; the follow-up period was 27.4 ± 58.27 
months).
Discussion
Angiosarcomas are malignant neoplasms that 
arise in the endothelial cells of vascular tissue; 
primary splenic angiosarcomas occur in the 
spleen. In general, angiosarcomas have poor 
prognoses, but this is particularly true of pri-
mary splenic angiosarcoma because of its high-
ly aggressive behavior and frequent metasta-
ses. The 6-month overall survival after dia- 
gnosis is less than 25% [3]. The rarity of this 
disease makes planning for treatment difficult. 
Splenectomy can be curative in early stages of 
the disease, and adjuvant chemotherapy with 
taxanes such as paclitaxel is also prescribed 
[3].
Primary splenic angiosarcomais extremely rare 
in pediatric patients, with only ten cases report-
ed worldwide (Table 1) [3-5]. Among these 
cases, the most common clinical presentation 
was splenomegaly, and most patients had left 
upper abdominal pain. Anemia was a common 
laboratory finding in these patients [6]. Pediatric 
angiosarcoma of organs other than the spleen 
appears to occur slightly more often in males 
than in females [7, 8]. 
The pathogenesis of primary splenic angiosar-
coma is not well characterized. Proposed caus-
al factors include exposure to ionizing radia-
tion, previous chemotherapy, or chemical ag- 
ents such as arsenic [9]. A case report sug-
gests that benign infantile hemangioma can be 
transformed into angiosarcoma by the muta-
tion of KRAS gene [10].
Our microscopic examination and immunohis-
tochemical study supports the diagnosis of 
primary splenic angiosarcoma. Microscopic ex- 
amination revealed variably pleomorphic endo-
thelial tumor cells lining irregularly anastomos-
ing vascular spaces, well-known and typical 
histological features of angiosarcoma. Frequent 
mitoses, multifocal necroses, and hemorrhage 
were also identified in the tissue. Other diagno-
ses that should be considered include heman-
gioma, littoral cell angioma, angiosarcoma, ly- 
mphangioma, or lymphangiosarcoma [6]. He- 
mangioma is a benign vascular neoplasm with 
well-formed vascular structures that has no 
atypical cells, necrosis, or infiltrations. The ca- 
se under consideration had high-grade nuclear 
atypia, frequent mitoses, and multifocal necro-
sis, which are presumed to be malignant. Li- 
ttoral cell angioma and angiosarcoma are com-
posed of splenic littoral cells, which have posi-
tive immunohistochemical staining for CD68 
and CD163. Lymphangioma or lymph angiosar-
coma are composed of lymphatic vessels and 
the endothelial cells of this tumor have variable 
immunohistochemical staining patterns with 
CD31 and CD34, but strongly positive staining 
with D2-40. We performed immunohistochemi-
cal staining for CD68 and D2-40 on the tumor 
cells in the case presented here, with negative 
results (data not shown). Thus, we are confi-
dent in our diagnosis.
Table 1. Cases of pediatric splenic angiosarcoma
Case No. Age (yr) Sex Tumor size (cm) Adjuvant therapy Metastasis
Survival  
(follow-up period) Reference
1 15 F NA NA Liver NA Ferrara [3]
2 12 F NA Radiotherapy Liver, bone Died (1 month) Sordillo [3]
3 1 M NA NA Liver, lung Died (3 months) Alt [3]
4 13 M 5 NA Liver, bone, serosal surfaces, skin Died (10 months) Wick [3]
5 15 M 17 Chemotherapy Liver Died (1 month) Kren [3]
6 2 F NA Chemotherapy Liver Alive (2 years) den Hoed [3]
7 7 M 13 None None Alive (16 years) Hsu [3]
8 17 F 19 None None Alive (16 months) Manouras [4]
9 13 F 5 None None Alive (7 months) Mejri [5]
10 3 F 17 Chemotherapy Liver Died (8 months) Serrano [3]
11 4 M 16 Chemotherapy Liver, bone Died (12 months) Present case
NA, not applicable.
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Angiosarcoma of the spleen is extremely 
uncommon in adults and even less common in 
children. It is an aggressive cancer, character-
ized by fast growth, frequent metastasis, and a 
poor prognosis. We have described a case of 
primary splenic angiosarcoma in a young child. 
This case report presents a pediatric splenic 
angiosarcoma which has the characteristic his-
tological and immunohistochemical features of 
this cancer.
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